Abbott receives U.S. approval of next-generation MitraClip®
Abbott announced the company has received FDA approval for the most advanced MitraClip™ heart valve repair device to treat mitral regurgitation. The latest approval for the fourth-generation MitraClip device, MitraClip G4, puts new enhancements into the hands of physicians across the U.S. July 15, 2019